Goldencross Pharma Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Goldencross Pharma Limited

Goldencross Pharma Limited, a active public limited company, was established on 21 January 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2000PLC123766. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹0.46 M.

Formerly known as Goldencross Pharma Private Limited. It upholds a compliant status. Employing 322 professional, Its leadership includes Swapn Bhawani Malpani (Additional Director), Ujjwal Prakash Shendre (Managing Director), Rajendra Kumar Chopra (Director). Past directors included Raghunathan Ananthanarayanan, Prabir Kumar Jha, Hemant Deshpande. It holds no open charges and ₹91.50 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at Tower A, 1St Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel,, Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2000PLC123766

  • Registration Number

    123766

  • Incorporation Date

    21 January 2000

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹0.46 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 0.46 M
  • Company Age 26 Year, 17 Days
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 91.50 Cr
  • Revenue Growth **** 0.89%
  • Profit Growth **** -6.56%
  • Ebitda **** -22.83%
  • Net Worth 6.97%
  • Total Assets **** 5.00%
Company report

Goldencross Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Goldencross Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Goldencross Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Swapn Bhawani Malpani Additional Director 16 Dec 2024 Current
Ujjwal Prakash Shendre Managing Director 24 May 2023 Current
Rajendra Kumar Chopra Director 03 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 12 Aug 2019 Past
Pramod Abcsdd Director 03 Jan 2019 Past
Pramod Abcsdd Director 04 Nov 2011 Past
Pramod Abcsdd Additional Director 20 Sep 2010 Past
Pramod Abcsdd Director 01 May 2017 Past
Pramod Abcsdd Additional Director 18 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Goldencross Pharma.

Goldencross Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.89% increase. The company also saw a slight decrease in profitability, with a 6.56% decrease in profit. The company's net worth moved up by a moderate rise of 6.97%.

Goldencross Pharma revenue growth over time
Goldencross Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.89%
*******
*******
*******
*******
Revenue from Operations
*******
 0.36%
*******
*******
*******
*******
Total Assets
*******
 5.00%
*******
*******
*******
*******
Profit or Loss
*******
 -6.56%
*******
*******
*******
*******
Net Worth
*******
 6.97%
*******
*******
*******
*******
EBITDA
*******
 -22.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Goldencross Pharma?

In 2023, Goldencross Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹915,000,000.00

Charges Breakdown by Lending Institutions
  • The Hongkong And Shanghai Banking Corporation Limited : 90.00 Cr
  • Credit Lyonnias : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
03 Feb 2009 The Hongkong And Shanghai Banking Corporation Limited ₹90.00 Cr Satisfied
18 Mar 2002 Credit Lyonnias ₹7.50 M Satisfied
08 Mar 2002 Credit Lyonnias ₹7.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Goldencross Pharma?

Goldencross Pharma has a workforce of 322 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Goldencross Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldencross Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Goldencross Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Goldencross Pharma Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Goldencross Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Swapn Bhawani Malpani was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2024 & has been associated with this company since 1 year 1 month . was completed.

  • Director Appointment

    The activity Pantha Milan Kundu was appointed as a CFO was appointed as a CFO on 22 Sep 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Ujjwal Prakash Shendre was appointed as a Managing Director was appointed as a Managing Director on 24 May 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Chirag Hotchandani was appointed as a Company Secretary was appointed as a Company Secretary on 02 Feb 2022 & has been associated with this company since 4 years 4 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Goldencross Pharma Limited?

The CIN of Goldencross Pharma Limited is U24239MH2000PLC123766.

Where is Goldencross Pharma Limited headquartered?

Goldencross Pharma Limited is headquartered at Tower A, 1St Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel,, Mumbai, Maharashtra, 400013.

When was Goldencross Pharma Limited incorporated?

Goldencross Pharma Limited was incorporated on 21 January 2000.

Who are the current directors of Goldencross Pharma Limited?

The current directors of Goldencross Pharma Limited are

What is the primary industry of Goldencross Pharma Limited?

The primary industry of Goldencross Pharma Limited is Manufacturing.

Is Goldencross Pharma Limited a listed company?

Goldencross Pharma Limited is unlisted.

What is the capital structure of Goldencross Pharma Limited?

The authorized capital of Goldencross Pharma Limited is ₹4.00 Cr, and the paid-up capital is ₹0.46 M.

What is the compliance status of Goldencross Pharma Limited?

The compliance status of Goldencross Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available